Prashanth K.B. Nagesh

Author

University of Tennessee Health Science Center ORCID

Also Known As

Nagesh, Prashanth K. B., P Nagesh, Prasanth Kumar Bhusetty Nagesh, Prashanth K. B Nagesh, Prashanth K. B. Nagesh, Prashanth K. Bhusetty Nagesh, Prashanth K. Nagesh, Prashanth K.B. Nagesh, Prashanth Kumar Bhusetty Nagesh, Prashanth Nagesh

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center The University of Texas Rio Grande Valley Memorial Sloan Kettering Cancer Center Center for Cancer Research University of California, Los Angeles

About

Prashanth K.B. Nagesh is an author at University of Tennessee Health Science Center specializing in medicine, radiation oncology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	497
2	Engineering	7	7	293
3	Cell Biology	5	5	168
4	Biomedical Engineering	4	4	216
5	Natural Sciences	1	1	12

Prashanth K.B. Nagesh

Publications

Citations

H-Index

Page 1

	Year	Citations
Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells Pallabita Chowdhury, Prashanth K.B. Nagesh, Elham Hatami, Journal of Colloid and Interface Science NanomedicineNanotherapeuticsTherapeutic NanomaterialsMedicinePolymer-drug Conjugate	2018	151
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer Prashanth K.B. Nagesh, Nia Johnson, Vijaya Kumar Naidu Boya, Colloids and Surfaces B Biointerfaces NanoparticlesNanomedicineMagnetismUrologyEngineering	2016	126
Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages Yuqing Gong, Pallabita Chowdhury, Prashanth K.B. Nagesh, Scientific Reports	2020	70
Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer Prashanth K.B. Nagesh, Elham Hatami, Pallabita Chowdhury, Cancers	2018	65
Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer Pallabita Chowdhury, Prashanth K.B. Nagesh, Sheema Khan, Acta Pharmaceutica Sinica B	2017	63
Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells Prashanth K.B. Nagesh, Pallabita Chowdhury, Elham Hatami, Scientific Reports	2020	60
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy Prashanth K.B. Nagesh, Pallabita Chowdhury, Elham Hatami, Cancers NanoparticlesNanomedicineEthylene GlycolEngineeringTherapeutic Nanomaterials	2018	51
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer Elham Hatami, Prashanth K.B. Nagesh, Meena Jaggi, European Journal of Pharmacology Gambogic Acid PotentiatesInduced Anticancer ActivityMedicinePharmacologyAnti-cancer Agent	2020	51
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence Prashanth K.B. Nagesh, Pallabita Chowdhury, Elham Hatami, ACS Applied Materials & Interfaces	2019	47
Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer Vivek K. Kashyap, Qinghui Wang, Saini Setua, Journal of Experimental & Clinical Cancer Research	2019	46

Page 1